Christine W Hockett1, Edward J Bedrick2, Philip Zeitler3, Tessa L Crume4, Stephen Daniels3, Dana Dabelea4. 1. Department of Epidemiology, Colorado School of Public Health, Aurora, CO. Electronic address: christine.hockett@ucdenver.edu. 2. Department of Epidemiology and Biostatistics, University of Arizona, Tucson, AZ. 3. Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. 4. Department of Epidemiology, Colorado School of Public Health, Aurora, CO.
Abstract
OBJECTIVE: To examine the associations of in utero exposure to maternal diabetes with surrogate measures of offspring pubertal timing (age at peak height velocity [APHV]) and speed of pubertal growth (peak height velocity [PHV]). STUDY DESIGN: Data from 77 exposed and 340 unexposed youth followed from age 2 to 19 years (51% non-Hispanic white, 50% female) were analyzed using the Exploring Perinatal Outcomes among Children study, a historical prospective cohort. Maternal diabetes status was collected from obstetric records, and child heights from 2 years to current age from pediatric records. Other covariates were collected during research visits. The superimposition by translation and rotation method, using height measurements (4-52 per participant), modeled APHV and PHV. Accelerated failure time analyses were used to test whether exposure to maternal diabetes was associated with younger APHV and faster PHV. RESULTS: Adjusting for child's sex, race/ethnicity, and socioeconomic status, median APHV was reached ~3 months earlier in youth exposed to maternal diabetes compared with unexposed youth (P < .03). Youth exposed to maternal diabetes had a faster PHV than unexposed youth: exposed girls had 10.5% greater median PHV compared with unexposed girls and exposed boys had a 4.0% greater median PHV compared with unexposed boys (P < .001 for exposure by sex interaction). CONCLUSIONS: Our findings provide evidence that exposure to maternal diabetes in utero is associated with earlier pubertal timing and faster pubertal growth. Whether earlier puberty or faster speed of pubertal growth mediates the association between maternal diabetes exposure and later chronic disease risk remains to be studied.
OBJECTIVE: To examine the associations of in utero exposure to maternal diabetes with surrogate measures of offspring pubertal timing (age at peak height velocity [APHV]) and speed of pubertal growth (peak height velocity [PHV]). STUDY DESIGN: Data from 77 exposed and 340 unexposed youth followed from age 2 to 19 years (51% non-Hispanic white, 50% female) were analyzed using the Exploring Perinatal Outcomes among Children study, a historical prospective cohort. Maternal diabetes status was collected from obstetric records, and child heights from 2 years to current age from pediatric records. Other covariates were collected during research visits. The superimposition by translation and rotation method, using height measurements (4-52 per participant), modeled APHV and PHV. Accelerated failure time analyses were used to test whether exposure to maternal diabetes was associated with younger APHV and faster PHV. RESULTS: Adjusting for child's sex, race/ethnicity, and socioeconomic status, median APHV was reached ~3 months earlier in youth exposed to maternal diabetes compared with unexposed youth (P < .03). Youth exposed to maternal diabetes had a faster PHV than unexposed youth: exposed girls had 10.5% greater median PHV compared with unexposed girls and exposed boys had a 4.0% greater median PHV compared with unexposed boys (P < .001 for exposure by sex interaction). CONCLUSIONS: Our findings provide evidence that exposure to maternal diabetes in utero is associated with earlier pubertal timing and faster pubertal growth. Whether earlier puberty or faster speed of pubertal growth mediates the association between maternal diabetes exposure and later chronic disease risk remains to be studied.
Authors: Louise G Grunnet; Susanne Hansen; Line Hjort; Camilla M Madsen; Freja B Kampmann; Anne Cathrine B Thuesen; Charlotta Granstrømi; Marin Strøm; Ekaterina Maslova; Ruth Frikke-Schmidt; Peter Damm; Jorge E Chavarro; Frank B Hu; Sjurdur F Olsen; Allan Vaag Journal: Diabetes Care Date: 2017-10-16 Impact factor: 19.112
Authors: D A Lawlor; A Fraser; R S Lindsay; A Ness; D Dabelea; P Catalano; G Davey Smith; N Sattar; S M Nelson Journal: Diabetologia Date: 2009-10-20 Impact factor: 10.122
Authors: Frank M Biro; Bin Huang; Patricia B Crawford; Anne W Lucky; Ruth Striegel-Moore; Bruce A Barton; Stephen Daniels Journal: J Pediatr Date: 2006-02 Impact factor: 4.406
Authors: Ai Kubo; Assiamira Ferrara; Cecile A Laurent; Gayle C Windham; Louise C Greenspan; Julianna Deardorff; Robert A Hiatt; Charles P Quesenberry; Lawrence H Kushi Journal: Am J Epidemiol Date: 2016-06-07 Impact factor: 4.897
Authors: Danielle H Bodicoat; Minouk J Schoemaker; Michael E Jones; Emily McFadden; James Griffin; Alan Ashworth; Anthony J Swerdlow Journal: Breast Cancer Res Date: 2014-02-04 Impact factor: 6.466
Authors: Cathy E Elks; Ken K Ong; Robert A Scott; Yvonne T van der Schouw; Judith S Brand; Petra A Wark; Pilar Amiano; Beverley Balkau; Aurelio Barricarte; Heiner Boeing; Ana Fonseca-Nunes; Paul W Franks; Sara Grioni; Jytte Halkjaer; Rudolf Kaaks; Timothy J Key; Kay Tee Khaw; Amalia Mattiello; Peter M Nilsson; Kim Overvad; Domenico Palli; J Ramón Quirós; Sabina Rinaldi; Olov Rolandsson; Isabelle Romieu; Carlotta Sacerdote; María-José Sánchez; Annemieke M W Spijkerman; Anne Tjonneland; Maria-Jose Tormo; Rosario Tumino; Daphne L van der A; Nita G Forouhi; Stephen J Sharp; Claudia Langenberg; Elio Riboli; Nicholas J Wareham Journal: Diabetes Care Date: 2013-11 Impact factor: 19.112
Authors: Wei Perng; Brandy M Ringham; Harry A Smith; Gregory Michelotti; Katerina M Kechris; Dana Dabelea Journal: Diabetologia Date: 2019-11-13 Impact factor: 10.122
Authors: Maggie A Stanislawski; Elizabeth Litkowski; Ruby Fore; Sheryl L Rifas-Shiman; Emily Oken; Marie-France Hivert; Ethan M Lange; Leslie A Lange; Dana Dabelea; Sridharan Raghavan Journal: Pediatr Rep Date: 2021-06-01